To ensure the plan’s success, the company has also strengthened its team by adding new, highly qualified personnel, selected according to strict criteria of technical and professional excellence.
\nDuring the plan’s implementation, AMSbiopharma has launched research projects and agreements with public and private entities that have allowed it to diversify its activities, enhance its staff’s expertise, and open new lines of work. These partnerships have strengthened the company’s competitiveness and generated key technical knowledge to address the challenges of a constantly evolving sector.<\/p>\n
Continuous improvement in quality and technology<\/p>\n
The company is driving continuous improvement of its quality protocols to ensure the highest safety, efficacy, and reliability of its analytical processes. Furthermore, technological innovations in data encryption and control have been incorporated, enhancing the traceability and transparency of its processes. These advancements are complemented by the commissioning of new facilities designed to strengthen AMSbiopharma’s capacity to develop high-value analytical services.<\/p>\n
The Innovation Plan has strengthened the entrepreneurial culture within the company. Thanks to synergies with the different companies in the AMSlab Group, knowledge sharing has been enhanced and initiatives have been promoted in which employees themselves have taken an active role in the development of innovative projects.<\/p>\n
Internationalization has been another pillar of the plan. AMSbiopharma has deployed market research strategies in new countries, with notable milestones such as the trade mission to North Carolina. This trip facilitated the establishment of strategic partnerships with research centers and opened new avenues of cooperation aimed at positioning Galicia as a key player in the international biotechnology sector.<\/p>\n
A commitment to Galician biotechnology<\/p>\n
With the completion of this plan, AMSbiopharma consolidates its commitment to technological innovation and continuous process improvement, reaffirming its role as a driving force in the biotechnology sector in Lugo and Galicia. \u201cThis project represents a step forward for AMSbiopharma on its path toward differentiation, internationalization, and innovation. Thanks to this investment, we are increasing our competitiveness by offering high-value services to the biopharmaceutical sector,\u201d the company’s management emphasized.<\/p>\n
AMSbiopharma’s Innovation Plan has been subsidized by GAIN, through the InnovaPeme 2024 business aid program.<\/p>\n
Bioga Press Office. 679.486.961.<\/p>\n","protected":false},"excerpt":{"rendered":"
Lugo, 30 de septiembre de 2025. \u2013 AMSbiopharma, laboratorio lucense perteneciente al Grupo AMSlab, ha presentado esta ma\u00f1ana en un evento…<\/p>\n","protected":false},"author":5,"featured_media":7613,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[53],"tags":[],"class_list":["post-8620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar-en"],"yoast_head":"\n